Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: A phase I-II trial-Reference-Cited by-同舟云学术

Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: A phase I-II trial

Published:2007-07 Issue:1 Volume:57 Page:66-71
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Stathopoulos George P.,Dimitroulis John,Toubis Michael,Katis Costas,Karaindros Dimitris,Stathopoulos John,Koutandos John

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Design and synthesis of inhibitors of folate-dependent enzymes as antitumor agents;Taylor;Adv Exp Med Biol,1993

2. LY231514, a pyrrolo (2,3-d) pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes;Shih;Cancer Res,1997

3. A phase I evaluation of multitargeted antifolate (MTA, LY231514) administered every 21 days using the modified continual reassessment method for dose escalation;Rinaldi;Cancer Chemother Pharmacol,1999

4. Phase I trial including pharmacokinetic and pharmacodynamic correlations of combinations paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer;Belani;J Clin Oncol,1999

5. Paclitaxel (175mg/m2) plus carboplatin versus paclitaxel (225mg/m2) plus carboplatin in non-small-cell lung cancer: a randomized study;Kosmidis;Semin Oncol,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas;Journal of Thoracic Oncology;2016-06

2. Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes;Therapeutic Advances in Medical Oncology;2016-05

3. A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer;Case Reports in Oncology;2014-07-05

4. Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer;Investigational New Drugs;2013-09-08

5. The place of pemetrexed in the management of non-small-cell lung cancer patients;Expert Review of Anticancer Therapy;2013-03